23155-0685 Octreotide Acetate - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

23155-0685

Brand Name:

Octreotide Acetate

Generic Name:

Octreotide Acetate

Dosage Form Name:

INJECTION, SOLUTION

Administration Route:

Intravenous

Subcutaneous

Substances:

Name: OCTREOTIDE ACETATE

Strength: 200.0

Unit: ug/mL

Packages:

Code: 23155-0685-31

Description: 5 mL in 1 VIAL, GLASS (23155-685-31)

Effective Date: May 25, 2022

Discontinued:

SEER*Rx Category:

Hormonal Therapy

Major Class:

Somatostatin Analog

Minor Class:

Orphan Drug Designation:

Status:

In Use